Independence Bank of Kentucky’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.55M | Buy |
33,967
+4,120
| +14% | +$886K | 0.96% | 19 |
|
|
2026
Q1 | $6.49M | Buy |
29,847
+2,572
| +9% | +$571K | 0.82% | 23 |
|
|
2025
Q4 | $6.23M | Buy |
27,275
+799
| +3% | +$182K | 0.78% | 24 |
|
|
2025
Q3 | $6.13M | Buy |
26,476
+366
| +1% | +$74.5K | 0.79% | 25 |
|
|
2025
Q2 | $4.85M | Buy |
26,110
+1,058
| +4% | +$197K | 0.69% | 30 |
|
|
2025
Q1 | $5.25M | Sell |
25,052
-771
| -3% | -$150K | 0.82% | 23 |
|
|
2024
Q4 | $4.59M | Buy |
25,823
+7,393
| +40% | +$1.36M | 0.71% | 29 |
|
|
2024
Q3 | $3.64M | Buy |
18,430
+1,909
| +12% | +$356K | 0.78% | 27 |
|
|
2024
Q2 | $2.83M | Buy |
16,521
+894
| +6% | +$148K | 0.75% | 25 |
|
|
2024
Q1 | $2.85M | Buy |
15,627
+4,097
| +36% | +$706K | 0.85% | 23 |
|
|
2023
Q4 | $1.79M | Buy |
11,530
+449
| +4% | +$65.5K | 0.63% | 40 |
|
|
2023
Q3 | $1.65M | Buy |
11,081
+174
| +2% | +$25.5K | 0.7% | 41 |
|
|
2023
Q2 | $1.47M | Sell |
10,907
-580
| -5% | -$85.1K | 0.6% | 51 |
|
|
2023
Q1 | $1.83M | Sell |
11,487
-475
| -4% | -$72.6K | 0.8% | 36 |
|
|
2022
Q4 | $1.93M | Sell |
11,962
-578
| -5% | -$88.6K | 0.87% | 32 |
|
|
2022
Q3 | $1.68M | Sell |
12,540
-96
| -0.8% | -$13.8K | 0.83% | 39 |
|
|
2022
Q2 | $1.94M | Sell |
12,636
-235
| -2% | -$35.9K | 0.87% | 36 |
|
|
2022
Q1 | $2.09M | Buy |
12,871
+401
| +3% | +$58.3K | 0.83% | 39 |
|
|
2021
Q4 | $1.69M | Sell |
12,470
-300
| -2% | -$35.4K | 0.69% | 48 |
|
|
2021
Q3 | $1.38M | Sell |
12,770
-16
| -0.1% | -$1.83K | 0.6% | 48 |
|
|
2021
Q2 | $1.44M | Sell |
12,786
-267
| -2% | -$30.1K | 0.64% | 47 |
|
|
2021
Q1 | $1.41M | Sell |
13,053
-119
| -0.9% | -$12.7K | 0.69% | 43 |
|
|
2020
Q4 | $1.41M | Sell |
13,172
-665
| -5% | -$63.9K | 0.73% | 43 |
|
|
2020
Q3 | $1.21M | Buy |
13,837
+318
| +2% | +$29.9K | 0.69% | 47 |
|
|
2020
Q2 | $1.33M | Sell |
13,519
-405
| -3% | -$35.7K | 0.86% | 36 |
|
|
2020
Q1 | $1.06M | Sell |
13,924
-205
| -1% | -$17.5K | 0.83% | 36 |
|
|
2019
Q4 | $1.25M | Sell |
14,129
-185
| -1% | -$15.4K | 0.81% | 38 |
|
|
2019
Q3 | $1.08M | Sell |
14,314
-1,270
| -8% | -$87.1K | 0.77% | 38 |
|
|
2019
Q2 | $1.13M | Sell |
15,584
-883
| -5% | -$69.4K | 0.89% | 37 |
|
|
2019
Q1 | $1.33M | Buy |
16,467
+988
| +6% | +$80.8K | 1.09% | 28 |
|
|
2018
Q4 | $1.43M | Buy |
15,479
+850
| +6% | +$74.7K | 1.3% | 23 |
|
|
2018
Q3 | $1.38M | Buy |
14,629
+1,405
| +11% | +$133K | 1.09% | 32 |
|
|
2018
Q2 | $1.23M | Buy |
13,224
+5
| +0% | +$488 | 1.03% | 35 |
|
|
2018
Q1 | $1.25M | Sell |
13,219
-910
| -6% | -$100K | 1.06% | 34 |
|
|
2017
Q4 | $1.37M | Buy |
+14,129
| New | +$1.33M | 1.17% | 29 |
|
Other funds holding ABBV
Independence Bank of Kentucky's ABBV Position: Q2 2026 in Review
Independence Bank of Kentucky increased its AbbVie (ABBV) stake by 14% in Q2 2026, buying an estimated $886K and bringing the position to 33,967 shares worth $8.55M. The position accounts for 0.96% of the portfolio, ranked #19.
Independence Bank of Kentucky first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. 2,806 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Independence Bank of Kentucky held 33,967 shares of AbbVie worth $8.55M as of Q2 2026.
- Independence Bank of Kentucky bought 4,120 AbbVie shares in Q2 2026, an estimated $886K.
- AbbVie made up 0.96% of Independence Bank of Kentucky's portfolio in Q2 2026, its #19 holding.
- Independence Bank of Kentucky first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- 2,806 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.